$0.30 EPS Expected for MedEquities Realty Trust Inc (MRT) This Quarter

Wall Street brokerages predict that MedEquities Realty Trust Inc (NYSE:MRT) will post earnings per share (EPS) of $0.30 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings, with estimates ranging from $0.29 to $0.33. MedEquities Realty Trust reported earnings of $0.31 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 3.2%. The firm is scheduled to announce its next earnings report on Friday, November 9th.

On average, analysts expect that MedEquities Realty Trust will report full year earnings of $1.19 per share for the current year, with EPS estimates ranging from $1.14 to $1.23. For the next financial year, analysts forecast that the company will report earnings of $1.20 per share, with EPS estimates ranging from $1.15 to $1.25. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that that provide coverage for MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last announced its earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.20). MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. The business had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million.

A number of brokerages have issued reports on MRT. Zacks Investment Research raised MedEquities Realty Trust from a “hold” rating to a “buy” rating and set a $13.00 target price on the stock in a research report on Wednesday, July 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $10.00 target price (down from $12.00) on shares of MedEquities Realty Trust in a research report on Friday, September 28th. ValuEngine lowered MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research report on Friday, September 14th. Royal Bank of Canada set a $10.00 target price on MedEquities Realty Trust and gave the company a “hold” rating in a research report on Sunday, August 12th. Finally, KeyCorp lowered MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 price target on the stock. in a research report on Wednesday, August 8th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the stock. MedEquities Realty Trust currently has an average rating of “Hold” and a consensus target price of $11.25.

In related news, Director Bluemountain Capital Managemen sold 3,955 shares of the company’s stock in a transaction that occurred on Friday, October 5th. The stock was sold at an average price of $9.13, for a total transaction of $36,109.15. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Over the last three months, insiders have sold 233,564 shares of company stock worth $2,026,401. Corporate insiders own 2.50% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the business. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in MedEquities Realty Trust in the second quarter worth $131,000. People s United Financial Inc. acquired a new stake in MedEquities Realty Trust in the second quarter worth $158,000. Bank of Montreal Can acquired a new stake in MedEquities Realty Trust in the second quarter worth $160,000. California Public Employees Retirement System acquired a new stake in MedEquities Realty Trust in the second quarter worth $171,000. Finally, Barclays PLC increased its position in MedEquities Realty Trust by 252.2% in the first quarter. Barclays PLC now owns 16,016 shares of the financial services provider’s stock worth $168,000 after buying an additional 11,469 shares during the period. 91.02% of the stock is currently owned by hedge funds and other institutional investors.

Shares of MRT opened at $8.73 on Wednesday. MedEquities Realty Trust has a 52-week low of $8.25 and a 52-week high of $12.00. The company has a market capitalization of $271.79 million, a price-to-earnings ratio of 7.11 and a beta of 0.65.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: Why do corrections happen?

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply